Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Low-dose dutasteride effectively and safely promotes hair growth in men.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Dutasteride is more effective for male pattern baldness than finasteride, and black cohosh extract BNO 1055 is as effective as conjugated estrogens in treating postmenopausal symptoms, with added benefits in reducing sweating and mental symptoms.

New anti-acne medications are being tested to offer alternatives to current treatments.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Both oral and topical minoxidil effectively regrow hair in men with similar results.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

Microneedling with 5% minoxidil improves hair loss in Chinese men by activating Wnt/ß-catenin pathway.

Topical finasteride is an effective and safer treatment for male hair loss.

Using both 5% spironolactone and 5% minoxidil together is safe and more effective for treating hair loss.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

Cellcurin serum significantly increased hair growth in people with androgenetic alopecia.

Prescription and alternative therapies for hair loss will be compared for effectiveness.

Australian dermatologists are updating their prescriptions for male pattern baldness.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Combination therapies are more effective for treating androgenetic alopecia than single treatments.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Oral contraceptives are effective for treating hyperandrogenism, while ovarian electrocautery is better for women with infertility.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Advocacy groups should avoid marketing partnerships that may imply drug endorsements.

The woman's symptoms and tests suggest her adrenal glands are producing too many male hormones.